PCCA Company Profile

Background

Professional Compounding Centers of America (PCCA) is a leading organization in the pharmaceutical compounding industry, dedicated to supporting the creation of personalized medications and innovative products that enhance patient care. Established in 1981 by a network of pharmacists, PCCA has been instrumental in providing high-quality products, education, and support to compounding pharmacies across the United States and internationally. The company's mission is to empower compounding pharmacies to meet the unique needs of their patients by offering a comprehensive range of resources and services.

Key Strategic Focus

PCCA's strategic focus encompasses several core objectives:

Comprehensive Support for Compounding Pharmacies: Providing a complete resource for independent compounding pharmacies, including access to industry-leading ingredients, education, and support.

Educational Initiatives: Offering training programs to ensure pharmacies comply with ever-changing United States Pharmacopeia (USP) standards and to enhance compounding success.

Product Innovation: Developing and supplying a diverse catalog of active pharmaceutical ingredients (APIs), proprietary bases, devices, and equipment to facilitate the preparation of customized medications.

Global Expansion: Serving a network of nearly 4,000 independent community pharmacists in the United States, Canada, Australia, and other countries, reflecting a strong international presence.

Financials and Funding

PCCA operates as a privately held company and has not publicly disclosed detailed financial information or funding history. The company is known for its robust financial health, enabling it to invest in product development, educational programs, and global expansion initiatives.

Pipeline Development

As a supplier to compounding pharmacies, PCCA does not engage in the development of pharmaceutical products or clinical trials. Instead, the company focuses on providing a comprehensive range of products and services to support the compounding process, including APIs, proprietary bases, devices, and equipment.

Technological Platform and Innovation

PCCA distinguishes itself through several technological platforms and innovations:

Proprietary Bases: Offering over 60 proprietary bases for use by member pharmacies, facilitating the preparation of customized medications.

Educational Resources: Providing training programs to ensure pharmacies comply with ever-changing USP standards and to enhance compounding success.

Clinical Support: Offering 24/7 guidance from a team of expert compounding pharmacists, ensuring high-quality patient care.

Leadership Team

PCCA's leadership team includes:

Jason Park: Chief Executive Officer

Lizabeth Harbin: Chief Culture Officer

Marc Dupont: Chief Financial Officer

Ilya Segal: Medical Doctor President

Gus Bassani: Chief Scientific Officer

Fabian Zaccardo: Chief Operating Officer

These leaders bring extensive experience in pharmacy, business management, and scientific research, contributing to PCCA's success in the compounding pharmacy industry.

Competitor Profile

Market Insights and Dynamics

The pharmaceutical compounding industry is characterized by a growing demand for personalized medicine, which requires customized drug formulations to meet individual patient needs. This trend is driven by advancements in medical research, an aging population, and a focus on individualized patient care. The market is competitive, with several key players offering similar products and services to support compounding pharmacies.

Competitor Analysis

PCCA's primary competitors include:

MEDISCA: Established in 1989, MEDISCA is a global leader in personalized medicine and pharmaceutical supply chain solutions, offering a comprehensive range of products and services to compounding pharmacies.

Fagron: Founded in Belgium in 1990, Fagron is a global leader in pharmaceutical compounding, operating in 60 countries and offering a vertically integrated approach to compounding.

Letco Medical: Acquired by Fagron in 2022, Letco Medical is a U.S.-based supplier of pharmaceutical raw materials, supplies, and equipment, serving compounding pharmacies across the country.

Strategic Collaborations and Partnerships

PCCA has formed strategic partnerships to enhance its offerings:

PersonalMed™ Network: In 2014, PCCA established PersonalMed™, a preferred provider network of Pharmacy Compounding Accreditation Board (PCAB)® Accredited PCCA member pharmacies, to partner with pharmacy benefits managers, health plans, and employers.

International Pharmaceutical Students Federation (IPSF): PCCA has partnered with IPSF to raise awareness about the importance of compounding within the pharmacy profession and to provide students with opportunities to develop their knowledge in designing and preparing compounded medicines.

Operational Insights

PCCA's operational strategy focuses on providing comprehensive support to compounding pharmacies, including access to high-quality products, educational resources, and clinical support. The company emphasizes quality control, with 14 checks and analyses performed on each chemical lot as it comes in and as it is repacked.

Strategic Opportunities and Future Directions

PCCA is well-positioned to capitalize on the growing demand for personalized medicine by continuing to expand its product offerings, enhance educational programs, and strengthen strategic partnerships. The company's commitment to quality and innovation supports its goal of being a leading resource for compounding pharmacies worldwide.